US Democrats fighting insulin prices might falter as midterms near
The upcoming midterm elections in the US could throw a wrench into Democrats’ plans to cap diabetes patients’ out-of-pocket insulin expenses.
by christian bundgaard, translated by daniel pedersen
Bipartisan support is needed before the US can secure more affordable insulin for diabetes patients, and bipartisan support is becoming more unlikely as November’s midterm elections in the US come closer, reports Reuters.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
US House of Representatives passes bill to cap insulin price
For subscribers
